ethyl methanesulfonate has been researched along with Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Allner, B; Allner, HT; Brendt, J; Derichsweiler, D; Froschauer, A; Hescheler, J; Hollert, H; Hölzel, BN; Pfannkuche, K; Schaffeld, M; Schiwy, A; Stahlschmidt-Allner, P | 1 |
| Gocke, E; Lavé, T; Müller, L; Pfister, T | 1 |
| Bürgin, H; Gocke, E; Müller, L; Pfister, T | 1 |
| Gocke, E; Müller, L | 1 |
| ROBERTS, JJ; WARWICK, GP | 1 |
| Anderson, D; Bibby, MC; Fearnley, J; Loadman, PM; Phillips, RM; Suggitt, M; Swaine, DJ; Volpato, M | 1 |
| Carlow, DA; Elliott, BE; Frost, P; Kerbel, RS; Liteplo, R | 1 |
2 review(s) available for ethyl methanesulfonate and Neoplasms
| Article | Year |
|---|---|
Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents, Alkylating; DNA; DNA Damage; Dose-Response Relationship, Drug; Drug Contamination; Ethyl Methanesulfonate; Female; HIV Protease Inhibitors; Humans; Male; Mice; Nelfinavir; Neoplasms; No-Observed-Adverse-Effect Level; Rats; Reproduction; Risk Assessment; Toxicity Tests | 2009 |
Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment.
Topics: Animals; Azacitidine; DNA; Ethyl Methanesulfonate; Humans; Mammary Neoplasms, Experimental; Methylation; Methylnitronitrosoguanidine; Models, Genetic; Mutation; Neoplasm Metastasis; Neoplasms; Neoplastic Stem Cells; Phenotype; Stem Cells | 1984 |
5 other study(ies) available for ethyl methanesulfonate and Neoplasms
| Article | Year |
|---|---|
Following the adverse outcome pathway from micronucleus to cancer using H2B-eGFP transgenic healthy stem cells.
Topics: Adverse Outcome Pathways; Animals; Animals, Genetically Modified; Carcinogens; Cell Line; Cell Nucleus; Cell Transformation, Neoplastic; Cells, Cultured; Cyclophosphamide; DNA Damage; Ethyl Methanesulfonate; Green Fluorescent Proteins; Histones; Humans; Mutagenicity Tests; Mutagens; Neoplasms; Rats; Stem Cells | 2020 |
Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Topics: Alkylating Agents; Animals; Dose-Response Relationship, Drug; Drug Contamination; Environmental Exposure; Ethyl Methanesulfonate; HIV Protease Inhibitors; Humans; Mice; Mutagens; Mutation; Nelfinavir; Neoplasms; No-Observed-Adverse-Effect Level; Rats; Reproduction; Risk Assessment; Toxicity Tests | 2009 |
Considerations regarding a permitted daily exposure calculation for ethyl methanesulfonate.
Topics: Alkylating Agents; Animals; Dose-Response Relationship, Drug; Drug Contamination; Environmental Exposure; Ethyl Methanesulfonate; Humans; Mutagenicity Tests; Mutagens; Neoplasms; No-Observed-Adverse-Effect Level; Risk Assessment | 2009 |
Mode of action of alkylating agents: formation of S-ethylcysteine from ethyl methanesulphonate in vivo.
Topics: Alkylating Agents; Antineoplastic Agents; Cysteine; Ethyl Methanesulfonate; Humans; Neoplasms | 1957 |
Comet assay and flow cytometry analysis of DNA repair in normal and cancer cells treated with known mutagens with different mechanisms of action.
Topics: Cell Cycle; Cells, Cultured; Comet Assay; Cross-Linking Reagents; DNA; DNA Damage; DNA Repair; DNA, Neoplasm; Ethyl Methanesulfonate; Flow Cytometry; Humans; Lymphocytes; Micronuclei, Chromosome-Defective; Mitomycin; Mutagens; Neoplasms | 2003 |